NANCY OHANIAN-GERHARD

LOS ANGELES, CA

General Payments — all program years on this page

$4,087.30

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 45
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,731.00 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,632.0020
Education $99.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Incyte Corporation $782.777
ABBVIE INC. $582.7511
Astellas Pharma US Inc $123.061
SpringWorks Therapeutics, Inc. $123.061
E.R. Squibb & Sons, L.L.C. $119.361

By program year

Program yearAmountRecords
2022 $311.753
2023 $2,044.5521
2024 $1,731.0021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1085809786 SpringWorks Therapeutics, Inc. $123.06 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101829217 E.R. Squibb & Sons, L.L.C. $119.36 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164437 ABBVIE INC. $123.79 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164439 ABBVIE INC. $123.06 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164441 ABBVIE INC. $123.79 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844740 ABBVIE INC. $4.00 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844746 ABBVIE INC. $18.94 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844751 ABBVIE INC. $20.57 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844756 ABBVIE INC. $118.14 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844762 ABBVIE INC. $9.10 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844768 ABBVIE INC. $12.81 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844773 ABBVIE INC. $8.89 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113844779 ABBVIE INC. $19.66 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139561332 Astellas Pharma US Inc $123.06 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141170637 Incyte Corporation $131.68 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141170651 Incyte Corporation $140.00 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141170663 Incyte Corporation $117.56 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141170669 Incyte Corporation $140.00 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141170671 Incyte Corporation $99.00 05/29/2024 Education Undisputed 01/23/2026 View at CMS
1141170673 Incyte Corporation $29.55 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141170685 Incyte Corporation $124.98 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.